Printer-friendly versionPrinter-friendly version

Burden and Prevention of Viral Hepatitis  in Portugal

Lisbon, Portugal, November 18-19, 2010

Thursday, November 18, 2010

Session 1  Opening and objectives
Chair:  Francisco George, Rui Tato Marinho

  • 09.00 - 09.30
  • Welcome and opening
  • Introduction of the participants
  • Introduction of the VHPB:     958 Kb(.pdf) prepared by  Pierre Van Damme
  • Objectives of the meeting:
    • Provide an overview of surveillance systems for infectious diseases;
    • Review the epidemiological situation on viral hepatitis;
    • Give an overview of the current prevention and control measures on viral hepatitis;
    • Discuss the progress achieved in hepatitis prevention 10 years after the introduction of Universal Hepatitis B vaccination;
    • Review the possible implementation of new prevention strategies, control measures and monitoring systems;
    • Discuss the successes, problems and barriers to overcome, and the way forward
  • Review of the meeting programme
  • Pre-meeting document  130 KB (.pdf)

Session 2 Overview of health care system and communicable disease prevention and control in Portugal
Chair:  Carlos Orta E Gomes, Rui Tato Marinho

09.30 – 10.00
Reforms in health system: “The Health Transformation Programme” in Portugal   419 Kb (.pdf)
Francisco George

10.00 – 10.20
Viral hepatitis surveillance system in Portugal  71 Kb (.pdf)
Mário Carreira

10.20 – 10.45 Coffee Break

Session 3 Epidemiology of viral hepatitis in Portugal
Chair: Fernando Ramalho, Claire Cameron

10.45 – 11.05
The epidemiological situation of hepatitis B  1.6 Mb (.pdf)
Rui Tato Marinho

11.05 – 11.25
The epidemiological situation of hepatitis E in Portugal  560 Kb (.pdf)
Sara Folgado Alberto

11.25 – 11.45
The epidemiological situation of hepatitis C in Portugal   676 Kb (.pdf)
Paula Peixe 

11.45 – 12.05 Discussion

12.05 – 13.30 Lunch

Chair: Leopoldo Matos, Heléne Norder

13.30 – 13.50
Molecular epidemiology of viral hepatitis C in Portugal    1 Mb (.pdf)
António Martinho

13.50 – 14.10
Molecular epidemiology of viral hepatitis B in Portugal    0.9 Mb (.pdf)
Ana Paula Mota

14.10 – 14.30
Epidemiology of viral hepatitis in pediatric patients    
Ana Isabel Lopes - hepatitis C 752 Kb(.pdf) 
Gonçalo Cordeiro Ferreira>- hepatitis B -  76 Kb (.pdf) 

14.30 – 14.50   Discussion

14.50 – 15.05   Coffee break

Session 4 Review of progress achieved in hepatitis prevention and control in Portugal
Chair: Guilherme Macedo,Alessandro Zanetti

15.05 – 15.25
The epidemiology of hepatitis A in Portugal: targeted vaccination versus universal immunization   250 Kb (.pdf)
Sandra Guedes

15.25 – 15.45
Viral hepatitis in haemodyalisis  3.3 Mb (.pdf)
Armando Carvalho

15.45 – 16.05
Liver Patients Association vision and activities 1.6 Mb (.pdf)
Emília Rodrigues

16.05 –16.25
The Syringe Exchange Programme in Portugal   3.3 Mb (.pdf)
Carla Torre

16.25 – 16.45
HBV immunization policies and lessons learnt after 10 years  559 Kb (.pdf)
Paula Valente

16.45 – 17.05 Discussion

17.05 End of the Day

 

Friday, November 19, 2010

Session 5  Different aspects of viral hepatitis in Portugal
Chair: Jorge Areias,  John Ward

09.00 – 09.20
Viral hepatitis and pregnancy. 1.3 Mb (.pdf)
Cristina Guerreiro

09.20 – 09.40
Epidemiology of coinfection (HIV, HCV) in Portugal.  702 KB (pdf)
Rui Sarmento e Castro

09.40 – 10.00
Liver transplant and viral hepatitis in Portugal  1.6 Mb (.pdf)
Eduardo Barroso

0.00 – 10.20
Economic aspects of viral hepatitis and liver disease in Portugal    430 Kb (.pdf)
José Giria

10.20 – 10.40 Discussion

10.40 – 11.00 Coffee break

Session 6  Evaluation of viral hepatitis prevention and control measures
Chair:José Velosa, Daniel Shouval

11.00 – 11.20
Results from the blood bank screening in Portugal  576 Kb (.pdf)
Gabriel de Olim

11.20 – 11.40
The epidemiology of viral hepatitis in Portuguese IV drug addiction    1.3 Mb (.pdf)
José Pádua,João Goulão 

11.40 – 12.00
Can Portugal learn from France?   103 Kb (.pdf)
Françoise Roudot-Thoraval

Impact of the hepatitis resolution adopted by the World Health Assembly (WHA 63.18)   368 Kb (.pdf)
Steven Wiersma

12.20 – 12.30 Discussion

12.30 – 14.00 Lunch

Session 7 Conclusions of the meeting
Chair: M. Carneiro de Moura , Mark Kane

14.15 – 14.45
Key note lecture: viral hepatitis  697 Kb(.pdf)
Daniel Lavanchy

14.45 – 15.15
Presentation of the VHPB meeting conclusions   94 Kb (.pdf)
D. FitzSimons
 

15.15 Close of the meeting

Tags: